CRIS
CRIS
NASDAQ · Biotechnology

Curis Inc

$0.44
0.00 (-0.23%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +961.2% upside
Low Target $2.81
Average Target $4.68
High Target $5.27
Current Price $0.44
Current
$0.44
Target
$4.68
$2.81 $4.68 avg $5.27
Scenario Analysis
Bear Case
$2.81
537.2%
Low target
Base Case
$4.68
+961.2%
Avg target
Bull Case
$5.27
+1,095.0%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$2.48
-82.2% from high
52-Week Low
$0.18
+144.2% from low
Target vs 52W High
$4.68
+88.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.2%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.6%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -38.5%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -48.0%